- Precision BioSciences Inc Extraordinary Shareholders Meeting TranscriptJan 18, 2024
- Precision BioSciences Inc at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Precision BioSciences Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 04, 2023
- Precision BioSciences Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 03, 2023
- Precision BioSciences Inc at HC Wainwright Cell Therapy Virtual Conference TranscriptFeb 28, 2023
- Precision BioSciences Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Precision BioSciences Inc Announces In Vivo Gene Editing Collaboration with Novatris TranscriptJun 22, 2022
- Precision BioSciences Inc Allogeneic CAR T Update- Conference Call TranscriptJun 08, 2022
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 10, 2022
- Precision BioSciences Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 27, 2021
- Precision BioSciences Inc PBCAR0191 Clinical Data Call TranscriptJun 04, 2021
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 10, 2021
- Precision BioSciences Inc Reacquires Global Rights to its Allogeneic CAR T Programs- Conference Call TranscriptApr 15, 2021
- Precision BioSciences Inc at Truist Securities Life Sciences Summit (April Series) TranscriptApr 13, 2021
- Precision BioSciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Cell Gene Meeting on the Mesa - Precision BioSciences TranscriptJan 08, 2021
- Precision BioSciences Inc Interim Data Results for PBCAR0191- Conference Call TranscriptDec 04, 2020
- Precision BioSciences Inc and Eli Lilly and Co In Vivo Gene Editing Collaboration - Conference Call TranscriptNov 20, 2020
Precision BioSciences Inc Annual Shareholders Meeting Transcript
Good morning, and welcome to the 2022 Precision BioSciences, Inc. virtual Annual Meeting of Stockholders. I would now like to turn the conference over to Mr. Michael Amoroso, CEO of the company. Please go ahead, sir.
Thank you. Good morning. My name is Michael Amoroso, and I'm the Chief Executive Officer of Precision BioSciences. I'm also a member of our Board of Directors and the Chairperson of today's meeting. I'm happy to welcome you to our Annual Meeting of Stockholders.
Before I call the meeting to order, as a reminder, our remarks during this meeting include any responses to questions today may include forward-looking statements. Forward-looking statements involve risks and uncertainties which are described in our SEC filings, including our fiscal 2021 annual report on Form 10-K; and our actual results may differ materially. Any forward-looking statements that we make during this meeting are based on our beliefs and assumptions today, and we don't have any obligation to update
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)